Cargando…
Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679667/ https://www.ncbi.nlm.nih.gov/pubmed/38022560 http://dx.doi.org/10.3389/fimmu.2023.1322220 |
| _version_ | 1785142210566553600 |
|---|---|
| author | Xuan, Zixue Song, Jian Yang, Quanjun Huang, Ping |
| author_facet | Xuan, Zixue Song, Jian Yang, Quanjun Huang, Ping |
| author_sort | Xuan, Zixue |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10679667 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106796672023-01-01 Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies Xuan, Zixue Song, Jian Yang, Quanjun Huang, Ping Front Immunol Immunology Frontiers Media S.A. 2023-11-13 /pmc/articles/PMC10679667/ /pubmed/38022560 http://dx.doi.org/10.3389/fimmu.2023.1322220 Text en Copyright © 2023 Xuan, Song, Yang and Huang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Xuan, Zixue Song, Jian Yang, Quanjun Huang, Ping Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| title | Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| title_full | Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| title_fullStr | Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| title_full_unstemmed | Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| title_short | Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| title_sort | editorial: studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced technologies |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679667/ https://www.ncbi.nlm.nih.gov/pubmed/38022560 http://dx.doi.org/10.3389/fimmu.2023.1322220 |
| work_keys_str_mv | AT xuanzixue editorialstudyingnovelimmunesignaturestargetsanddrugsinhepatobiliarytumorsbasedonadvancedtechnologies AT songjian editorialstudyingnovelimmunesignaturestargetsanddrugsinhepatobiliarytumorsbasedonadvancedtechnologies AT yangquanjun editorialstudyingnovelimmunesignaturestargetsanddrugsinhepatobiliarytumorsbasedonadvancedtechnologies AT huangping editorialstudyingnovelimmunesignaturestargetsanddrugsinhepatobiliarytumorsbasedonadvancedtechnologies |